ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 331

$277K Total Retail Price of All Prescriptions

Rank: 59 out of 331

412 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,071 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 515 439 1 1
METFORMIN HCL 406 346 2 2
SYNTHROID 298 281 3 11
OMEPRAZOLE 285 243 4 5
AMLODIPINE BESYLATE 258 208 5 6
LOSARTAN-HYDROCHLOROTHIAZIDE 192 155 6 14
LEVOTHYROXINE SODIUM 172 152 7 9
FLUTICASONE PROPIONATE 156 133 8 60
SERTRALINE HCL 154 149 9 28
LISINOPRIL 149 135 10 13
GABAPENTIN 148 143 11 7
LEVOXYL 140 128 12 49
FENOFIBRATE 132 110 13 48
PRAVASTATIN SODIUM 129 105 14 20
LOSARTAN POTASSIUM 111 94 15 8
HYDROCHLOROTHIAZIDE 102 82 16 10
METOPROLOL SUCCINATE 102 102 16 24
GLIMEPIRIDE 101 100 18 21
FUROSEMIDE 94 94 19 15
RANITIDINE HCL 93 79 20 4
ENALAPRIL MALEATE 88 82 21 3
ZOLPIDEM TARTRATE 84 78 22 22
ASPIRIN EC 84 75 22 27
AMLODIPINE BESYLATE-BENAZEPRIL 81 74 24 47
DIOVAN 81 81 24 69
LORATADINE 79 70 26 93
PAROXETINE HCL 70 67 27 80
DONEPEZIL HCL 69 67 28 38
CARVEDILOL 69 58 28 33
ISOSORBIDE MONONITRATE ER 69 61 28 31
METOPROLOL TARTRATE 65 65 31 16
TAMSULOSIN HCL 65 60 31 34
NAMENDA 65 65 31 63
CIPROFLOXACIN HCL 64 61 34 36
BENAZEPRIL HCL 64 54 34 193
NAPROXEN SODIUM 62 51 36 116
ALENDRONATE SODIUM 62 56 36 17
PANTOPRAZOLE SODIUM 62 60 36 41
ATENOLOL 60 60 39 12
TRAMADOL HCL-ACETAMINOPHEN 60 51 39 18
IRBESARTAN 59 59 41 73
CLOPIDOGREL 58 55 42 39
CLOTRIMAZOLE-BETAMETHASONE 54 49 43 43
PLAVIX 53 48 44 46
VERAPAMIL ER 51 51 45 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.